BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31948308)

  • 1. Successful treatment of a patient with Kasabach-Merritt syndrome and multiple giant hepatic hemangiomas.
    Liu Y; Wu X; Ye L; Xu H
    J Int Med Res; 2020 Jan; 48(1):300060519898358. PubMed ID: 31948308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Hemangioma with Kasabach-Merritt Syndrome in an Adult Patient.
    Oak CY; Jun CH; Cho EA; Lee DH; Cho SB; Park CH; Joo YE; Kim HS; Rew JS; Choi SK
    Korean J Gastroenterol; 2016 Apr; 67(4):220-223. PubMed ID: 27112250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of Kasabach-Merritt Syndrome and placental chorioangioma in a premature infant.
    Gültekin ND; Yilmaz FH; Altunhan H; Findik S; Tokgöz H; Çalişkan Ü
    J Neonatal Perinatal Med; 2018; 11(2):209-213. PubMed ID: 29991142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Transplantation for Giant Hemangioma Complicated by Kasabach-Merritt Syndrome: A Case Report and Literature Review.
    Zhao Y; Legan CE
    Am J Case Rep; 2022 May; 23():e936042. PubMed ID: 35796001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Propranolol treatment in Kasabach-Merritt Syndrome secondary to congenital hepatic hemangioma. Clinical case].
    Selzer Soria EM; Malla I
    Arch Argent Pediatr; 2021 Feb; 119(1):e65-e69. PubMed ID: 33458995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of neonate effectively treated with everolimus for giant hepatic hemangioma complicated with congenital duodenal atresia and Kasabach-Merritt syndrome.
    Watanabe S; Manabe M; Miyata M; Naoe A; Suzuki T
    J Neonatal Perinatal Med; 2021; 14(3):437-440. PubMed ID: 33325401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of propranolol for congenital hepatic hemangioma with Kasabach-Merritt phenomenon.
    Kawahara Y; Nijima H; Suzuki Y; Furukawa R; Morimoto A
    Pediatr Int; 2017 May; 59(5):634-636. PubMed ID: 28402071
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful combination therapy of propranolol and prednisolone for a case with congenital Kasabach-Merritt syndrome.
    Mizutani K; Umaoka A; Tsuda K; Kakeda M; Habe K; Yamanaka K; Suyama M; Mizutani H
    J Dermatol; 2017 Dec; 44(12):1389-1391. PubMed ID: 28771780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficiency of an mTOR Inhibitor in Kasabach-Merritt Phenomenon with Indolent Tufted Angioma: A Case Report.
    Nardin C; Boccara O; Eschard C; Bayaram M; Dabudyk T; Aubin F; Puzenat E
    Acta Derm Venereol; 2017 Jul; 97(7):851-852. PubMed ID: 27958609
    [No Abstract]   [Full Text] [Related]  

  • 11. Kasabach-Merritt Syndrome: a case study of successful treatment with vincristine and propranolol.
    Mazhar A; Ghouse AN; Shahid S; Samad L
    J Pak Med Assoc; 2023 Dec; 73(12):2476-2479. PubMed ID: 38083937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of an adult with Kasabach-Merritt syndrome using thalidomide, vincristine, and prednisone.
    Huang YH; Zhou DB; Han B; Li T; Wang SJ
    J Int Med Res; 2019 Apr; 47(4):1810-1814. PubMed ID: 30806107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of steroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon using sirolimus.
    Tan X; Zhang J; Zhou S; Liu Z; Zhang T; Xia J
    J Dermatol; 2018 May; 45(5):580-583. PubMed ID: 29356076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region.
    Su L; Wang D; Fan X
    J Oral Maxillofac Surg; 2015 Jan; 73(1):92-8. PubMed ID: 25511959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin.
    Bozkaya H; Cinar C; Ünalp ÖV; Parildar M; Oran I
    Wien Klin Wochenschr; 2015 Jun; 127(11-12):488-90. PubMed ID: 25471004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of Kasabach-Merritt syndrome with prednisone and epsilon-aminocaproic acid.
    Dresse MF; David M; Hume H; Blanchard H; Russo P; Van Doesberg N; Rivard GE
    Pediatr Hematol Oncol; 1991; 8(4):329-34. PubMed ID: 1669958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory Kasabach-Merritt phenomenon successfully treated with sirolimus, and a mini-review of the published work.
    Wang Z; Li K; Dong K; Xiao X; Zheng S
    J Dermatol; 2015 Apr; 42(4):401-4. PubMed ID: 25728547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unresectable giant hepatic hemangioma and Kasabach-Merritt syndrome].
    About I; Capdeville J; Bernard P; Lazorthes F; Boneu B
    Rev Med Interne; 1994; 15(12):846-50. PubMed ID: 7863122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic angiosarcoma with clinical and histological features of Kasabach-Merritt syndrome.
    Wadhwa S; Kim TH; Lin L; Kanel G; Saito T
    World J Gastroenterol; 2017 Apr; 23(13):2443-2447. PubMed ID: 28428724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.